Diabetes patient blood glucose management method and system based on reinforcement learning, medium and terminal

A technology that strengthens learning and management methods. It is applied in neural learning methods, promoting communication between doctors or patients, and informatics. It can solve problems such as lack of distinction and failure to consider the correlation of patients' blood sugar sequences, and achieve good blood sugar control. Effect

Pending Publication Date: 2021-06-04
上海市第四人民医院
View PDF4 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In the latest study, Fox I et al. proposed a blood glucose control method based on DQN, which is based on the design of artificial pancreas technology, and uses the blood glucose value measured by the continuous blood glucose monitoring device to design the patient's state. After the blood sugar level and insulin injection level, the insulin level to be injected at the next moment can be given. This method does not distinguish between basal insulin, which is used to maintain the body’s blood sugar stability, and bolus, which is used to offset the rise in blood sugar caused by intake. Insulin dosage; Sun Q et al. proposed a blood glucose control model based on the Actor-Critic structure, using the blood glucose information of the patient on the previous day to predict the next day's basal insu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diabetes patient blood glucose management method and system based on reinforcement learning, medium and terminal
  • Diabetes patient blood glucose management method and system based on reinforcement learning, medium and terminal
  • Diabetes patient blood glucose management method and system based on reinforcement learning, medium and terminal

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The implementation of the present invention is described below through specific specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention can also be implemented or applied through other different specific implementation modes, and various modifications or changes can be made to the details in this specification based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that, in the case of no conflict, the following embodiments and features in the embodiments can be combined with each other.

[0031] It should be noted that the diagrams provided in the following embodiments are only schematically illustrating the basic ideas of the present invention, and only the components related to the present invention are shown in the diagrams rather than the number, shape and siz...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a diabetes patient blood glucose management method and system based on reinforcement learning, a medium and a terminal. The method comprises the following steps: training a decision network model based on a reinforcement learning algorithm to obtain a trained decision network model; acquiring current state information of a diabetes patient; and sending the current state information to the trained decision network model, so that the trained decision network model determines the insulin injection amount corresponding to the diabetes patient at the next future moment based on the current state information, and blood glucose management of the diabetic patient is achieved. According to the method, the decision network model is trained by a reinforcement learning algorithm based on historical blood sugar data and future carbohydrate intake of the diabetes patient, so that the relationship between carbohydrate and blood sugar change is utilized from historical information of the diabetes patient, the purpose of better controlling blood sugar is achieved, and the conditions of irregular intake time and intake amount of carbohydrates can be better adapted.

Description

technical field [0001] The present invention relates to the field of physics, in particular to measurement technology, in particular to a method, system, medium and terminal for blood sugar management of diabetic patients based on reinforcement learning. Background technique [0002] Diabetes has become one of the chronic diseases that seriously endanger national health. Since diabetes itself is difficult to cure, and related complications will have a serious impact on patients, the treatment of diabetes has gradually become the focus of attention. [0003] Artificial pancreas is currently one of the best ways to achieve closed-loop control of blood sugar in diabetic patients. It consists of three parts, continuous blood glucose monitoring device (CGMS), insulin pump and control algorithm; among them, CGMS mainly collects relevant blood sugar data from patients , the control algorithm inputs these data into the preset algorithm according to the time series data obtained by C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G16H20/10G16H20/60G16H50/30G16H80/00G06N3/04G06N3/08
CPCG16H20/10G16H20/60G16H50/30G16H80/00G06N3/08G06N3/045
Inventor 王从容王悦石易琦饶卫雄赵钦佩李江峰竺金浩
Owner 上海市第四人民医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products